Since TWISTs were reported as the master regulator in tumor metastasis in 2004 [29], multiple studies have demonstrated TWIST as a potential prognostic marker for many cancers, including myeloid leukemia, oral, esophageal, lung, breast, cervical and bladder cancer [27, 30–34]. The gene discussed is TWIST1; the disease is urinary bladder cancer.